HIV-1 antigen screening to be discussed at Rep. Shays' blood safety hearing.
This article was originally published in The Gray Sheet
Executive Summary
HIV-1 ANTIGEN SCREENING TO BE DISCUSSED AT REP. SHAYS' BLOOD SAFETY HEARING scheduled for Oct. 12. The session before the House Government Reform & Oversight/Human Resources and Intergovernmental Relations Subcommittee, chaired by Rep. Christopher Shays (R-Conn), will examine "HHS management of threats to the nation's blood supply," the subcommittee reports. Shays says that "of particular interest in this hearing will be the status of the HIV-1 antigen testing program."